Literature DB >> 20448034

Regulation of Weibel-Palade body exocytosis by alpha-synuclein in endothelial cells.

Kwang Soo Kim1, Ji-Young Park, Ilo Jou, Sang Myun Park.   

Abstract

alpha-Synuclein is a small presynaptic protein implicated in the pathogenesis of Parkinson disease. Nevertheless, its physiological roles and mechanisms remain incompletely understood. alpha-Synuclein is not only expressed in neurons but also in the vascular endothelium, which contains intracellular granules called Weibel-Palade bodies (WPBs) that contain a number of chemokines, adhesive molecules, and inflammatory cytokines. This study explored whether the exocytosis of WPB is regulated by alpha-synuclein. Phorbol 12-myristate 13-acetate-, thrombin-, or forskolin-induced von Willebrand factor release or translocation of P-selectin from endothelial cells were inhibited by alpha- and beta-synuclein but not gamma-synuclein. Three point mutants (A30P, A53T, and E46K) found in familial Parkinson disease also inhibited WPB exocytosis similar to that of wild-type alpha-synuclein. Furthermore, the negative regulation of WPB exocytosis required the N terminus or the nonamyloid beta-component of Alzheimer disease amyloid region of alpha-synuclein, but not the C-terminal acidic tail, and alpha-synuclein affected WPB exocytosis through interference with RalA activation by enhancing the interaction of RalGDS-beta-arrestin complexes. Immuno-EM analysis revealed that alpha-synuclein was localized close to WPBs. These findings imply that alpha-synuclein plays as a negative regulator in WPB exocytosis in endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448034      PMCID: PMC2898423          DOI: 10.1074/jbc.M110.103499

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

1.  The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity.

Authors:  N Ostrerova-Golts; L Petrucelli; J Hardy; J M Lee; M Farer; B Wolozin
Journal:  J Neurosci       Date:  2000-08-15       Impact factor: 6.167

2.  alpha-synuclein promotes mitochondrial deficit and oxidative stress.

Authors:  L J Hsu; Y Sagara; A Arroyo; E Rockenstein; A Sisk; M Mallory; J Wong; T Takenouchi; M Hashimoto; E Masliah
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.

Authors:  A Abeliovich; Y Schmitz; I Fariñas; D Choi-Lundberg; W H Ho; P E Castillo; N Shinsky; J M Verdugo; M Armanini; A Ryan; M Hynes; H Phillips; D Sulzer; A Rosenthal
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

4.  Chaperone-like activity of synucleins.

Authors:  J M Souza; B I Giasson; V M Lee; H Ischiropoulos
Journal:  FEBS Lett       Date:  2000-05-26       Impact factor: 4.124

5.  Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons.

Authors:  D D Murphy; S M Rueter; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

6.  A Drosophila model of Parkinson's disease.

Authors:  M B Feany; W W Bender
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

7.  Induction of neuronal death by alpha-synuclein.

Authors:  A R Saha; N N Ninkina; D P Hanger; B H Anderton; A M Davies; V L Buchman
Journal:  Eur J Neurosci       Date:  2000-08       Impact factor: 3.386

8.  Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects.

Authors:  R Borghi; R Marchese; A Negro; L Marinelli; G Forloni; D Zaccheo; G Abbruzzese; M Tabaton
Journal:  Neurosci Lett       Date:  2000-06-16       Impact factor: 3.046

9.  Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli.

Authors:  C A da Costa; K Ancolio; F Checler
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

10.  In situ and in vitro study of colocalization and segregation of alpha-synuclein, ubiquitin, and lipids in Lewy bodies.

Authors:  W P Gai; H X Yuan; X Q Li; J T Power; P C Blumbergs; P H Jensen
Journal:  Exp Neurol       Date:  2000-12       Impact factor: 5.330

View more
  15 in total

1.  The TNF-α/NF-κB signaling pathway has a key role in methamphetamine-induced blood-brain barrier dysfunction.

Authors:  Vanessa Coelho-Santos; Ricardo A Leitão; Filipa L Cardoso; Inês Palmela; Manuel Rito; Marcos Barbosa; Maria A Brito; Carlos A Fontes-Ribeiro; Ana P Silva
Journal:  J Cereb Blood Flow Metab       Date:  2015-04-22       Impact factor: 6.200

2.  Proteolytic cleavage of extracellular α-synuclein by plasmin: implications for Parkinson disease.

Authors:  Kwang Soo Kim; Yu Ree Choi; Ji-Young Park; Jung-Ho Lee; Dong Kyu Kim; Seung-Jae Lee; Seung R Paik; Ilo Jou; Sang Myun Park
Journal:  J Biol Chem       Date:  2012-05-22       Impact factor: 5.157

3.  α-Synuclein concentration increases over time in plasma supernatant of single donor platelets.

Authors:  Catherine M Stefaniuk; Hong Hong; Clifford V Harding; Robert W Maitta
Journal:  Eur J Haematol       Date:  2018-07-28       Impact factor: 2.997

4.  Initial assessment of α-synuclein structure in platelets.

Authors:  Catherine M Stefaniuk; June Schlegelmilch; Howard J Meyerson; Clifford V Harding; Robert W Maitta
Journal:  J Thromb Thrombolysis       Date:  2021-11-19       Impact factor: 5.221

Review 5.  Hemostasis components in cerebral amyloid angiopathy and Alzheimer's disease.

Authors:  Nicole Ziliotto; Francesco Bernardi; Fabrizio Piazza
Journal:  Neurol Sci       Date:  2021-05-27       Impact factor: 3.307

6.  α-Synuclein membrane association is regulated by the Rab3a recycling machinery and presynaptic activity.

Authors:  Robert H C Chen; Sabine Wislet-Gendebien; Filsy Samuel; Naomi P Visanji; Gang Zhang; Diana Marsilio; Tammy Langman; Paul E Fraser; Anurag Tandon
Journal:  J Biol Chem       Date:  2013-01-23       Impact factor: 5.157

7.  Blocking von Willebrand factor for treatment of cutaneous inflammation.

Authors:  Carina Hillgruber; Annika K Steingräber; Birgit Pöppelmann; Cécile V Denis; Jerry Ware; Dietmar Vestweber; Bernhard Nieswandt; Stefan W Schneider; Tobias Goerge
Journal:  J Invest Dermatol       Date:  2013-06-28       Impact factor: 8.551

8.  Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.

Authors:  Qiuyu Zhu; Munekazu Yamakuchi; Sara Ture; Maria de la Luz Garcia-Hernandez; Kyung Ae Ko; Kristina L Modjeski; Michael B LoMonaco; Andrew D Johnson; Christopher J O'Donnell; Yoshimi Takai; Craig N Morrell; Charles J Lowenstein
Journal:  J Clin Invest       Date:  2014-09-17       Impact factor: 14.808

9.  Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.

Authors:  Shyra J Gardai; Wenxian Mao; Birgitt Schüle; Michael Babcock; Sue Schoebel; Carlos Lorenzana; Jeff Alexander; Sam Kim; Heather Glick; Kathryn Hilton; J Kent Fitzgerald; Manuel Buttini; San-San Chiou; Lisa McConlogue; John P Anderson; Dale B Schenk; Frederique Bard; J William Langston; Ted Yednock; Jennifer A Johnston
Journal:  PLoS One       Date:  2013-08-23       Impact factor: 3.240

10.  Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease.

Authors:  Gergely Tóth; Shyra J Gardai; Wagner Zago; Carlos W Bertoncini; Nunilo Cremades; Susan L Roy; Mitali A Tambe; Jean-Christophe Rochet; Celine Galvagnion; Gaia Skibinski; Steven Finkbeiner; Michael Bova; Karin Regnstrom; San-San Chiou; Jennifer Johnston; Kari Callaway; John P Anderson; Michael F Jobling; Alexander K Buell; Ted A Yednock; Tuomas P J Knowles; Michele Vendruscolo; John Christodoulou; Christopher M Dobson; Dale Schenk; Lisa McConlogue
Journal:  PLoS One       Date:  2014-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.